« Previous
Next »
Titles
- Resuming normal drug and biologics manufacturing operations during the COVID-19 public health emergency1
- Revised recommendations for reducing the risk of Zika virus transmission by blood and blood components1
- Revised recommendations for reducing the risk of human immunodeficiency virus transmission by blood and blood products1
- Revised recommendations to reduce the risk of transfusion-transmitted malaria1
- Rhode Island's Pediatric Practice Enhancement Project: parents helping parents and practitioners1
- Risk evaluation and mitigation strategies: modifications and revisions2
- Round 2 competitive bidding for CPAP/RAD: disrupted access unlikely for devices, inconclusive for supplies1
- Round two competitive bidding for enteral nutrition: continued access for vast majority of beneficiaries1
- Round two competitive bidding for oxygen: continued access for vast majority of beneficiaries1